Twenty exceptional individuals living with Duchenne muscular dystrophy will receive a scholarship of up to $5,000 as they pursue their post-secondary education. Route 79, The Duchenne Scholarship Program was created in 2018 by Sarepta Therapeutics, to recognise community involvement and personal essay. Now in its fifth year, the Program has been expanded to include siblings of individuals with Duchenne in recognition of the impact that a diagnosis of Duchenne may have on the entire family.
On behalf of Sarepta and the selection committee, we are thrilled to announce the recipients of Route 79, The Duchenne Scholarship Program, for the 2022-2023 academic year. These twenty outstanding students are exemplary in their commitment and dedication to their studies. In addition to conveying their intellectual curiosity, the essays from this year’s recipients spoke to the power and strength of community and the importance of advocating for growth and change at a personal and societal level. We are honored to support these young adults as they pursue their educational goals, and we wish them great success in the school year ahead and wherever their academic journey takes them.
Diane Berry, senior vice president, Global Health Policy, Government and Patient Affairs, Sarepta.